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ABSTRACT: Allosteric enzymes contain a wealth of catalytic diversity that remains distinctly underutilized for biocatalysis. Tryp-
tophan synthase is a model allosteric system and a valuable enzyme for the synthesis of non-canonical amino acids (ncAA). Previ-
ously, we evolved the β-subunit from Pyrococcus furiosus, PfTrpB, for ncAA synthase activity in the absence of its native partner 
protein PfTrpA. However, the precise mechanism by which mutation activated TrpB to afford a stand-alone catalyst remained en-
igmatic. Here, we show that directed evolution caused a gradual change in the rate-limiting step of the catalytic cycle. Concomitant-
ly, the steady-state distribution of intermediates shifts to favor covalently bound Trp adducts, which is associated with increased 
thermodynamic stability of these species. The biochemical properties of these evolved, stand-alone TrpBs converge on those in-
duced in the native system by allosteric activation. High resolution crystal structures of the wild-type enzyme, an intermediate in 
the lineage, and the final variant, encompassing five distinct chemical states, show that activating mutations have only minor struc-
tural effects on their immediate environment. Instead, mutation stabilizes the large-scale motion of a sub-domain to favor an other-
wise transiently populated closed conformational state. This increase in stability enabled the first structural description of Trp cova-
lently bound in a catalytically active TrpB, confirming key features of catalysis. These data combine to show that sophisticated 
models of allostery are not a prerequisite to recapitulating its complex effects via directed evolution, opening the way to engineer-
ing stand-alone versions of diverse allosteric enzymes. 
INTRODUCTION 
Biocatalysis is emerging as a powerful methodology for 
green, sustainable chemical synthesis.1,2 This development 
relies on decades of biochemical insights into enzyme 
structure and mechanism to guide engineering of natural 
enzymes into convenient synthetic tools. While active-site 
mutagenesis of non-essential residues is a facile way to 
alter substrate specificity and improve function, residues 
throughout a protein’s structure influence catalytic activity. 
These remote mutations are reminiscent of allosteric ef-
fects, where binding of a ligand or partner protein (effector) 
distant from the active site alters enzyme function. Many, if 
not most, enzymes are allosterically regulated and are an 
important source of catalytic diversity.3 Unfortunately, re-
moval of the native effector often results in loss of activity 
and can be a major barrier to the successful implementation 
of enzymes as biocatalysts.4 This scenario is exemplified 
by the enzyme tryptophan synthase (TrpS, EC 4.2.1.20), 
which is a model system for understanding allosteric func-
tion as well as a highly desirable biocatalyst for the synthe-
sis of non-canonical amino acids (ncAAs).5–8 
TrpS is comprised of two subunits, TrpA (α-subunit) and 
TrpB (β-subunit) that function as a heterodimeric pair in an 
αββα complex.9 In the native catalytic cycle, indole glycer-
ol phosphate (IGP) binds in the α-subunit where a retro-
aldol reaction releases indole, which diffuses through a 
molecular tunnel into the β-subunit (Figure 1a).10 There, 
TrpB uses its pyridoxal phosphate (PLP) cofactor to effect 
the β-substitution of the L-serine (Ser) hydroxyl group for 
indole to yield L-tryptophan (Trp). This system evolved to 
coordinate the TrpB catalytic cycle with the release of in-
dole,10,11 which could otherwise be lost by diffusion 
through the cellular membrane. When added exogenously, 
indole and its analogues react to produce over 30 different 
ncAAs.5–7,12–14 While this β-substitution reaction occurs 
wholly within the β-subunit, isolation of either subunit re-
sults in a significant decrease in catalytic efficiency.8,15   
Previously, we used directed evolution to identify vari-
ants of TrpB from Pyrococcus furiosus (PfTrpB) that have 
high stand-alone catalytic activity.12 An intermediate from 
this lineage harboring five mutations, PfTrpB4D11, was sub-
sequently evolved to catalyze β-substitution with  
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Figure 1. Mechanism of tryptophan synthase. a) TrpS is a heterodimeric enzyme in an αββα arrangement (only one dimer is shown for 
clarity). In the overall catalytic cycle indole-3-glycerol phosphate binds in the α-subunit (TrpA), which catalyzes a retroaldol reaction that 
releases indole into an intermolecular tunnel extending into the β-subunit (TrpB), where indole condenses with L-serine in a pyridoxal 
phosphate (PLP)-dependent reaction to yield L-tryptophan. (b) The mechanism of TrpB catalysis with the gem-diamine intermediates omit-
ted for clarity. Residues from the enzyme are shown in blue, the PLP cofactor is in black, and the intermediates are in red. 
L-threonine (Thr) to yield β-methyltryptophan, resulting in 
the enzyme PfTrpB2B9.13 Recently, we discovered that TrpS 
is also proficient at the β-substitution of Thr.16 Hence, 
PfTrpB2B9 was serendipitously evolved to exhibit a reactivi-
ty profile similar to the allosterically activated PfTrpB. 
These engineering efforts relied predominantly on random 
mutagenesis and mutations in PfTrpB2B9 are distant from 
the active site. Spectroscopic data showed similarities be-
tween the engineered and allosterically activated enzymes, 
however several important questions were outstanding. 
Specifically, how did the mutations introduced by directed 
evolution affect the rate limiting step of the reaction and 
how do they perturb the structure of TrpB? The ability to 
predict distal, activating mutations would enable rapid en-
gineering of allosteric enzymes. Given the broad interest in 
understanding how enzyme structure and dynamics pro-
mote catalysis,17–22 and the specific applicability of PfTrpB 
as a platform for synthesis of ncAAs,12,13 we sought a more 
detailed understanding of how these ‘allostery-mimicking’ 
mutations enhance catalytic activity.  
The β-substitution reaction catalyzed by TrpB proceeds 
through at least nine elementary steps (Figure 1b).8 In its 
resting state, the PLP cofactor is bound to an active-site 
lysine (Lys82, PfTrpB numbering) through a protonated 
Schiff-base linkage.23 This species undergoes transimina-
tion with Ser to form an external aldimine intermediate, 
E(Aex1).
12,24 A subdomain (residues 95-161) that mediates 
communication between the α- and β-subunits of TrpS, 
named the COMM domain, undergoes a rigid-body motion 
upon E(Aex1) formation into a partially closed state.
24 
Deprotonation of Cα by Lys82 forms a carbanion that is 
resonance- stabilized as a quinonoid, E(Q1). Rapid elimina-
tion of the hydroxyl group forms an electrophilic amino 
acrylate, E(A-A), and concludes Stage I of the catalytic 
cycle.25 These chemical steps are correlated with further 
motion of the COMM domain into a fully closed confor-
mation.26 In the native complex, formation of E(A-A) is 
tightly coupled to IGP binding and release of indole by the 
α-subunit.10 Stage II of the catalytic cycle is initiated when 
indole adds into E(A-A) to form a quinonoid, E(Q2) that is 
rapidly deprotonated to restore aromaticity of the indole 
ring.27 Stereospecific protonation at Cα completes Trp for-
mation as E(Aex2), which is released from the enzyme via 
transimination to complete the catalytic cycle.28   
Elucidating the protonation states of the numerous titrat-
able moieties in the TrpB active site at the various stages of 
catalysis is an active area of research.29 Reaction with ni-
trogen nucleophiles, such as indoline and 2-aminophenol, 
stalls the catalytic cycle of TrpS from Salmonella typhi-
murium (StTrpS), enabling structural analysis of quinonoid 
intermediates.30–32 These studies have indicated that proton 
transfer between the phenolic group of PLP and the Schiff 
base may occur during the catalytic cycle. However, 
PfTrpS performs a facile β-substitution with N-nucleophiles 
indoline and indazole,12 indicating there are subtle differ-
ences in transition state stabilization between the meso-
philic and thermophilic homologs. Additionally, it has long 
been hypothesized that indole is rendered nucleophilic via 
interaction with Glu104.33 However, mutational studies 
have found that this residue is dispensable if compensatory 
allosteric ligands34 or activating mutations35 are added. 
These features notwithstanding, the β-substitution reaction 
of TrpB is relatively well-understood considering its com-
plexity. Guided by this wealth of knowledge, we performed 
kinetic, spectroscopic, and thermodynamic analysis for 
each enzyme in the lineage leading to PfTrpB2B9. Compari-
son of these properties to the native PfTrpS complex re-
vealed that evolution for stand-alone function mimics struc-
tural and mechanistic features of natural allosteric activa-
tion. 
RESULTS 
The rate-limiting step shifts with both directed evolu-
tion and TrpA binding. The first two evolutionary steps 
toward a stand-alone TrpB selected for increased activity 
with Ser and indole. The resultant enzyme, PfTrpB4D11, had 
a 4-fold higher catalytic efficiency for indole compared to 
the native complex (Table 1).12 Two subsequent rounds of 
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 Table 1. Biochemical parameters of native, engineered, and allosterically activated PfTrpB enzymes 
Enzyme Additional 
Mutations 
kcat 
(s–1) 
KM 
L-Ser (mM) 
KM 
indole (µM) 
kcat/ KM 
L-Ser 
(M–1s–1) 
kcat/ KM 
indole 
(M–1s–1) 
Kinetic 
Isotope 
Effecta 
KD L-Trp 
(µM) 
PfTrpB N/A 0.31 ± 0.02b 1.2 ± 0.2b 80 ± 10b 260 3,900 2.77 ± 0.09 1200 ± 250 
PfTrpB2G9 T292S 1.1 ± 0.2b 0.84 ± 0.04b 14 ± 3b 1,300 78,00 1.46 ± 0.08 168 ± 12 
PfTrpB4D11 E17G, I68V, 
F274S, T321A 
2.2 ± 0.2b 1.2 ± 0.2b 11 ± 2b 1,800 200,000 1.37 ± 0.08 30 ± 4 
PfTrpB4G1 F95L 1.3 ± 0.05 0.45 ± 0.08 <10 2,900 >130,000 1.17 ± 0.11 16 ± 1 
PfTrpB2B9 I16V, V384A 0.94 ± 0.02 0.34 ± 0.03 <10 2,800 >94,000 1.12 ± 0.03 13 ± 1 
PfTrpS N/A 1.0 ± 0.1b 0.6 ± 0.1b 20 ± 2b 1,600 50,000 1.01 ± 0.04 < 10 
All reactions conducted with 1-60 µM enzyme in potassium phosphate buffer pH 8.0 at 75 °C. a Kinetic isotope effect determined as the 
ratio of the initial velocities of product formation using Ser and d3-Ser. 
b These values from ref. 10. See materials and methods for details. 
Error bars represent the standard error for each parameter determined from a non-linear fit. 
evolution selected for increased activity with Thr.13 A lin-
gering question from these studies was how the native ac-
tivity was altered after selection for β-methyl tryptophan 
synthesis. Therefore, we determined the kinetic parameters 
of these latter variants in the native reaction with Ser. Addi-
tion of the single mutation F95L to PfTrpB4D11 decreased 
the rate of Trp formation (bringing it closer to that of the 
native PfTrpS complex) but also reduced the KM for each of 
the substrates (Table 1). These changes were reiterated with 
the addition of I16V and V384A, yielding PfTrpB2B9.  This 
final variant had a KM for Ser approximately two-fold low-
er than that of PfTrpS, and the KM for indole decreased 
below the sensitivity of our assay. Notably, the kcat is indis-
tinguishable between PfTrpB2B9 and PfTrpS. 
 To obtain more detailed mechanistic information, we de-
termined the rate-limiting step (RLS) of PfTrpB catalysis. 
A previous study by Lane and Kirschner probed the mech-
anism of the mesophilic homolog from Escherichia coli, 
EcTrpB, using mono-deuterated Ser at both the α- and β-
positions.25 They observed that Cα–H deprotonation is rate 
limiting with a primary kinetic isotope effect (KIE) of 2.5 
and no measurable secondary KIE using β-deuteroserine. 
We used two techniques to measure a KIE for the β-
substitution reaction of PfTrpB using indole and either Ser 
or (2,3,3-d3)-L-serine (d3-Ser). First, we compared the ini-
tial velocities and observed a clear primary KIE of 2.77 ± 
0.09, indicating that Cα–H deprotonation is the RLS of 
catalysis (Table 1). We also measured the isotopic ratio of 
Trp products from direct competition reactions using 
equimolar d3-Ser and Ser, which indicated a KIE of 2.61 ± 
0.08. This competition experiment is sensitive to differ-
ences in KM for the isotopes, and agreement with the KIE 
determined from initial velocity experiments under saturat-
ing conditions indicates that changes in KM are negligible. 
Further insight into the deprotonation of E(Aex1) was ob-
tained with UV-vis spectroscopy. Each of the quasi-stable 
species in the TrpB reaction have distinct UV-vis absorp-
tion that provides a convenient spectroscopic handle for 
probing the catalytic cycle (Figure 1b).8 Upon incubation 
with Ser, we observed a steady-state buildup of the E(Aex1) 
state that precedes the rate-limiting deprotonation (Figure 
2a). 
We determined the KIE for each TrpB variant in the line-
age to PfTrpB2B9 by measuring initial velocities with (d3-) 
Ser. The single mutation T292S causes a significant reduc-
tion in the KIE to 1.46 ± 0.08 (Table 1), which is correlated 
with an approximate halving of the E(Aex1) population in 
steady state (Figure 2b). This trend continued for each of 
the stand-alone enzymes. The KIE decreased, down to 1.12 
± 0.03 for PfTrpB2B9 with a concomitant shift in the steady-
state spectra with Ser (Figure 2c-e). As the population of 
E(Aex1) in steady state decreased, we observed a comple-
Figure 2. Steady-state distribution of 
TrpB catalytic intermediates. The black 
line is the spectrum of each enzyme 
prior to the addition of substrate, and 
λmax corresponds to E(Ain) (see Figure 
1). Catalysis was initiated by the addi-
tion of 20 mM Ser and 1 mM indole. 
The resulting steady-state distribution is 
shown in the purple trace. Indole was 
consumed within 1-2 minutes and the 
steady state shifts to reflect intermedi-
ates in just stage I of catalysis, shown in 
the red line. Spectra were collected with 
20 µM enzyme in 0.2 M potassium 
phosphate buffer, pH 8.0 and normal-
ized with the value of the absorbance of 
the E(Ain) peak at 412 nm set to 1.0 for 
ease of comparison. 
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 mentary increase in the E(A-A) peak. We also performed 
these experiments with the native PfTrpS complex and ob-
served a KIE of 1.01 ± 0.04, with no significant population 
of E(Aex1) in the steady state (Figure 2f). Notably, these 
kinetic properties of thermostable PfTrpS closely mimic 
those of EcTrpS, which displays a KIE of 1.2 at pH 7.6 and 
similarly accumulates E(A-A) in the steady state.25 Hence, 
the remote activation of TrpB either by mutation or the 
native allosteric effector accelerates Cα deprotonation, sta-
bilizes E(A-A), and causes a new step to become rate-
limiting. 
Stage II of catalysis is rate-limiting for activated en-
zymes. Further mechanistic insight came from analysis of 
the steady-state spectra when indole was present, and thus 
both stages of the catalytic cycle were accessible. Under 
these conditions, the spectrum of PfTrpB was unchanged: 
the E(Aex1) species, which precedes the RLS of PfTrpB 
catalysis still accumulated in the steady state (Figure 2a). In 
contrast, the steady-state spectra of the activated enzymes 
revealed that E(A-A) no longer accumulated in solution 
when indole was present. Reaction with indole yields a new 
peak in the steady-state spectrum with λmax = 435 nm, cor-
responding to E(Aex2), and a shoulder at 475 nm.
8 The 
quinonoid species that is initially formed, E(Q2), is highly 
unstable and rearomatization of the indole ring drives the 
formation of E(Q3), which we assign as the absorption band 
at 475 nm (Figure 2b-f).8 This steady-state scenario is simi-
lar to EcTrpS, where rapid kinetic studies show that C–C 
bond formation is two orders of magnitude faster than the 
steady-state rate of product formation,28 and that the proton 
transfer that converts E(Q3) into E(Aex2) is the RLS of ca-
talysis. Consequently, the steady-state distribution of the 
EcTrpS reaction has a prominent E(Q3) peak.
36 The E(Q3) 
shoulder that we observe for PfTrpS is less pronounced, 
and it is not clear which step (or a combination of steps) 
determines the steady-state rate. While further insight into 
PfTrpB catalysis requires rapid kinetic analysis, two points 
germane to the present study are clear. First, deprotonation 
of E(Aex1) is the RLS of isolated PfTrpB catalysis but not 
that of the activated enzymes, where stage II of catalysis is 
rate limiting. More importantly, the remote activation of 
TrpB by directed evolution resulted in complex, incremen-
tal kinetic changes that converged on a profile similar to 
allosterically-activated PfTrpB.  
Thermodynamic properties of stand-alone enzymes 
mirror PfTrpS. An alternative route to probe the catalytic 
cycle of TrpB is to enter from the reverse direction by addi-
tion of Trp. Under these conditions, we observed no degra-
dation of Trp and the resultant spectra represent not the 
steady-state distribution of intermediates, but their thermo-
dynamic distribution. Previously, we found that isolated 
PfTrpB binds Trp non-covalently under crystallographic 
conditions,12 and the present study conforms to this obser-
vation. When saturating Trp is present, E(Aex2) and E(Q3) 
are populated at very low levels at 75 °C (Figure 3). The 
small change in absorption caused by addition of Trp was 
monitored at 475 nm and fit well to a single-site binding 
isotherm, indicating that each unit of the dimer functions 
independently (Figure S1). We observed that PfTrpB binds 
Trp weakly (KD = 1.2 mM, Table 1). The first enzyme in 
our evolutionary lineage of stand-alone TrpBs contains the 
single T292S mutation and binds Trp ~7.1-fold tighter (KD 
= 168 µM) and, surprisingly with a larger fraction of cova-
lently bound E(Aex2) and E(Q3) adducts. We repeated this 
experiment and found that each generation binds Trp more 
tightly than the one preceding it, down to KD = 12 µM for 
PfTrpB2B9 and the population of Trp that binds covalently 
increased. The spectrum of the native PfTrpS complex has 
KD < 10µM and a slightly larger fraction of Trp covalently 
bound compared to stand-alone enzymes (Figure 3). 
      
Figure 3. Spectra of PfTrpB enzymes with saturating Trp. The 
black line corresponds to the E(Ain) state of the cofactor. Each 
colored spectrum corresponds to a unique TrpB enzyme saturated 
with Trp. The peak at ~435 nm corresponds to the E(Aex2) inter-
mediate and the shoulder at ~ 275 nm corresponds to the E(Q3) 
intermediate. The spectra were normalized with the value of the 
absorbance of the E(Ain) peak at 412 nm set to 1.0 for cross-
comparison. 
Intriguingly, the population of Trp adducts for all activat-
ed TrpBs is slightly higher under steady-state conditions 
than at equilibrium (Figure S2), consistent with the hypoth-
esis that multiple-steps in stage II contribute to rate limita-
tion. However, the population difference between steady-
state and equilibrium for PfTrpS are negligible, suggesting 
a subtle difference in the RLS. Generally, though, the bio-
chemical data provided here establish that directed evolu-
tion and allosteric activation increase the activity of PfTrpB 
by accelerating Cα–H deprotonation of E(Aex1) and stabi-
lizing covalently-bound Trp adducts.  
These data provide a rich picture of the complex effects 
induced by mutational activation. Given that all mutations 
are distal to the active site, we were particularly interested 
in what structural changes were caused by directed evolu-
tion. Because many of the catalytic intermediates are ob-
servable through X-ray crystallography, we hypothesized 
that structural comparison of PfTrpB to the stand-alone 
enzymes in the presence of substrate or product would pro-
vide insight into of how allostery-mimicking mutations 
influence these states and thereby control activity.  
Conformational changes of PfTrpB can be observed 
crystallographically. We have previously grown crystals 
of native PfTrpB and determined high resolution structures 
with Ser and Trp bound to the enzyme.12 This crystal form 
features two copies of the TrpB dimer in the asymmetric 
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Figure 4. Effects of Ser binding on PfTrpB enzymes (a) Overlay of TrpB structures in different states shows the correlation between the 
conformational state of the COMM domain (colored) and the chemical state of the active site. The extended open state (green, PDB ID: 
5T6M) was observed when a single molecule of β-methyl tryptophan serendipitously bound in a cleft connecting the active site to solvent. 
The open state in the absence of a ligand bound is in gray (PDB ID: 5DVZ). The external aldimine of serine, E(Aex1), is observed with a 
partially closed conformation in blue (PDB ID: 6AMH). Formation of the electrophilic E(A-A) intermediate is coupled to formation of a 
fully closed conformational state in red (PDB ID: 5VM5). (b) Comparison of the ligand free state of PfTrpB (PDB ID: 5DVZ), PfTrpB4D11 
(PDBID: 6AMC) and PfTrpB2B9 (PDBID: 6AM7) reveals only a minor conformational change at residue Asp300. (c) PfTrpB4D11 binds Ser 
as E(Aex1). Fo-Fc omit map (green) is contoured at 3.0 σ, PDB ID: 6AMH (d) A single subunit of PfTrpB
2B9 binds Ser as the E(A-A) in-
termediate. Fo-Fc omit map (green) is contoured at 3.0 σ, PDB ID: 5VM5)  
unit, providing four unique snapshots of the active site in 
each structure. Alignment of the four distinct PfTrpB pro-
tamers shows they are largely identical (RMSD = 0.32 ± 
0.05 Å2). In the absence of a ligand, PfTrpB crystallizes in 
an ‘open’ state with K82 covalently bound to the cofactor 
as E(Ain) (Figure 1b, 4a).12,37 The degree of ‘openness’ of 
TrpB enzymes refers to the large rigid-body motion of the 
COMM domain as well as movement of several sidechains 
flanking the active site (F274, H275, D300, Y301), which 
together comprise ~25% of the protein sequence. Previous-
ly, we showed Ser binds to PfTrpB as E(Aex1) and triggers 
a partial closure of the COMM domain (Figure 4a), demon-
strating that PfTrpB can enter the catalytic cycle in crystal-
lo. The StTrpS complex, has been the model system for 
understanding structural aspects of TrpS allostery and ca-
talysis. There, it was shown that that population of E(A-A) 
is coupled to closure of the COMM domain38 and that the 
closed state is highly stabilized by the α-subunit.39 While 
our solution data so far conform to this paradigm, counter-
intuitively, the structure of PfTrpS displays a more open β-
subunit compared to PfTrpB alone (Figure S3). This “ex-
tended open” conformation closely matches both the re-
cently reported structure of PfTrpB with a single molecule 
of β-MeTrp bound inside a molecular tunnel (Figure 4, 
S3),13 as well as the structure of the tryptophan synthase 
complex from Mycobacterium tuberculosis with a potent 
allosteric inhibitor bound in the tunnel.40 These observa-
tions support assignment of this conformation as function-
ally important for the transport of substrate and product 
between solution and the active site.  
PfTrpB
4D11
 has perplexingly similar structural fea-
tures to PfTrpB. Crystallization of the activated variants 
proved far more challenging than was anticipated. Exten-
sive optimization of crystallization conditions for 
PfTrpB4D11 yielded crystals that grew sporadically under 
conditions similar to wild type, from which we determined 
a structure at 1.93 Å resolution. Surprisingly, PfTrpB4D11 
has a comparable degree of closure as PfTrpB. The similar-
ity held for the local environment of each ‘allostery-
mimicking’ mutation (Figure S4). Of the five mutations 
that separate PfTrpB4D11 from wild type, the only notable 
change we observed was adjacent to T292S, in residue 
D300. In native PfTrpB, D300 populates two confor-
mations and is either hydrogen-bonded to T292 or rotated 
into the active site where it is poised to hydrogen bond to 
the hydroxyl of the E(Aex1) intermediate (Figure 4b). D300 
is not resolved in every subunit of the PfTrpB4D11 structure, 
attesting to its flexibility, but when present it is does not 
form the analogous hydrogen bond with S292.  
We could not initially produce enough crystals of 
PfTrpB4D11 for soaking experiments. However, cross-
seeding with microcrystals of native PfTrpB provided a 
reliable route to crystallization of mutant enzymes. Ser was 
soaked into pre-formed crystals of PfTrpB4D11 and we de-
termined a 1.63-Å co-crystal structure. As described above, 
PfTrpB4D11 binds Ser predominantly as E(A-A) in solution 
(Figure 2c). We were therefore surprised to observe that Ser 
bound crystallographically as E(Aex1) (Figure 4c). Never-
theless, observation of this catalytic intermediate afforded a 
clean comparison with PfTrpB. Most of the structure is 
unchanged upon ligand binding (Figure S5), except for the 
large rigid body motion of the COMM domain (Figure 4a), 
which moves ~3.0 Å to produce an active site that is indis-
tinguishable from the wild-type enzyme (Figure S6). One 
small difference between PfTrpB and PfTrpB4D11 was ob-
served at the extremity of the COMM domain, residues 
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150-165, where the E(Aex1) state of PfTrpB
4D11 forms an 
incrementally more closed state (~0.3 Å). Comparison to 
the StTrpS structures suggests a further 2.5-Å shift is need-
ed to adopt a fully closed state. The structural similarity 
between PfTrpB4D11 and the native enzyme was reiterated 
when we determined the structure of the Trp bound enzyme 
at 1.97 Å. Whereas solution data suggested that Trp would 
bind covalently as the E(Aex2) intermediate (Figure 3), we 
instead obtained a non-covalently bound Trp structure of 
PfTrpB4D11 that was virtually identical to the corresponding 
state for native PfTrpB (Figure 5a, S7). 
The closed conformation of PfTrpB is destabilized at 
low temperature. Small conformational differences be-
tween solid and solution state structures are common, and it 
has been observed that domain orientation can be impeded 
in crystallo.
41 Cryogenic temperatures can also impact the 
crystallographic ensembles.42,43 This crystal form of TrpB, 
however, is quite flexible and the observation of an alto-
gether different active-site species was puzzling. Previous 
studies established that PfTrpB displays a non-linear Ar-
rhenius effect, suggesting that the kinetic mechanism may 
be temperature-dependent.37 A similar observation was 
made with StTrpB, where rigorous studies have shown the 
relative stability of the catalytic intermediates and the RLS 
of catalysis are indeed temperature-dependent, causing 
non-linear Arrhenius kinetics.44 It was hypothesized that 
these changes are driven by a redistribution of the confor-
mational ensemble from closed to open states as tempera-
ture decreases. Notably, our biochemical studies were per-
formed at 75 °C, whereas crystals were grown at room 
temperature, a difference of over 50 °C. We repeated the 
Ser- and Trp-binding experiments with PfTrpB4D11 at 25 °C 
and observed a marked change (Figure 5b, S9). Ser bound 
predominantly as E(Aex1) and Trp bound non-covalently, 
which agreed with our crystallographic observations. Alt-
hough structural analysis of PfTrpB4D11 yielded no obvious 
structural changes caused by mutation, it remained possible 
that mutation exerts a considerable effect on the closed 
state of TrpB, but that this effect is hidden by the large de-
crease in temperature required for crystallization. Indeed, 
analogy to StTrpS suggested that the elusive E(A-A) and 
E(Aex2) states could only be observed crystallographically 
if the closed state of TrpB were sufficiently stable. We as-
sayed the Ser- and Trp-binding properties of PfTrpB2B9 at 
25 °C and, although the population of E(A-A) and E(Aex2) 
clearly decreases at lower temperature (Figure 5e, S8), 
there remained a significant population that might be crys-
tallographically observable.   
Ligand binding to PfTrpB
2B9
 induces a fully closed 
conformational state. Cross-seeding with PfTrpB was 
required to produce crystals of PfTrpB2B9, allowing deter-
mination of a ligand-free structure at 1.47-Å resolution. 
Again, the local structural features of this mutant enzyme 
are almost identical to wild type in the absence of a sub-
strate (Figure S4), despite the introduction of eight muta-
tions that cause a dramatic change in catalytic activity. As 
with PfTrpB4D11, a minor change was observed near the 
T292S mutation (Figure 4b). We soaked crystals of 
PfTrpB2B9 with Ser and determined a 1.67-Å structure that 
displayed, in three of the four protomers of the asymmetric 
unit, Ser bound as E(Aex1) in a manner indistinguishable 
from native PfTrpB and PfTrpB4D11 (Figures S5, S6). 
Again, the COMM domain was slightly more closed, this 
time ~0.3 Å more so than PfTrpB4D11 at its maximum ex-
tent. In one subunit, however, we were pleased to observe 
density that clearly indicated the E(A-A) intermediate was 
Figure 5. Tryptophan binding by stand-alone TrpB enzymes. (a) L-Trp binds non-covalently to PfTrpB4D11 in crystallo. Fo-Fc omit map 
(green) is contoured at 3.0 σ, PDB ID: 6AMI. (b) The affinity of PfTrpB4D11 for Trp is significantly decreased at room temperature, as is 
the population of covalent adducts. (c) Comparison of PfTrpB2B9-E(Aex2) with the previous structure determined with an active site 
mutation (PDBID: 2TYS, blue) shows changes in the orientation of the intermediate. (d) Addition of L-Trp to PfTrpB2B9 crystals shows 
the product covalently bound as E(Aex2). Fo-Fc omit map (green) is contoured at 3.0 σ, PDB ID: 6AM8.  (e) The affinity of PfTrpB
2B9 
for Trp is decreased at room temperature, but there is observable population of the E(Aex2) and E(Q3) intermediates. (f) Covalent Trp 
binding (purple) causes COMM domain closure that is comparable to the state observed when E(A-A) is bound.  
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formed in the active site (Figure 4d). This subunit showed a 
further 3.3-Å rigid-body movement of the COMM domain 
towards the active site to form a fully closed state (Figure 
4a). This is the first report of the closed conformation of an 
isolated TrpB enzyme and it closely matches structures of 
E(A-A) in StTrpS, which required addition of strong allo-
steric effectors to stabilize the otherwise fleeting confor-
mation (Figure S9).26,38 We also attempted to determine a 
structure with Ser and the non-reactive substrate analog 
skatole bound in the active site. While no skatole was ob-
served in the 2.09-Å structure, we did observe E(A–A) 
formation and COMM closure in three out of four pro-
tomers of the asymmetric unit and E(Aex1) in the last. To-
gether these structures showcase the flexibility afforded 
TrpB within this crystal form and provide multiple snap-
shots of chemical and structural states leading up to E(A–
A) formation.  
 Structural characterization of the Trp external al-
dimine. Lastly, we determined the structure of PfTrpB2B9 at 
1.83-Å with Trp soaked into the active site. Two of the pro-
tomers bound Trp non-covalently in a manner analogous to 
the Trp-soaked structures of PfTrpB and PfTrpB4D11 (Figure 
S7). Intriguingly, when Trp was added to native StTrpS 
crystals formed under conditions that stabilize the closed 
conformation, only non-covalent Trp binding was ob-
served.32 We were therefore gratified to see density in two 
subunits of PfTrpB2B9 that clearly show Trp covalently 
bound as the E(Aex2) intermediate (Figure 5d). This obser-
vation was particularly exciting because, despite the exten-
sive characterization of TrpS, the only previous structure of 
the E(Aex2) state was determined using an inactive variant 
generated by mutation of the catalytic Lys to Thr.24 Com-
pared to the structure of the inactive enzyme, Cα of 
E(Aex2) in PfTrpB
2B9 is displaced by 0.6 Å (Figure 5c, 
S10) and the carboxylate moiety is rotated ~40° such that 
the hydrogen bond network now matches the orientation in 
the E(Aex1) state. This orientation also places the Cα-H 
bond periplanar to the π-system, in position to form a qui-
nonoid state upon deprotonation. The indole sidechain is 
tilted ~35° and forms van der Waals contacts with L161, 
which forms a strained partially-eclipsed conformation (χ2 
= 130°) in one of the two protomers, attesting to the tight 
steric complementarity in the active site. Lastly, we affirm 
that the E(Aex2) forms with the COMM domain in a fully 
closed state (Figure 5f).  
Mutational activation shifts the conformational ensem-
ble of TrpB. As discussed above, each crystal structure 
reported here contains four molecules of TrpB in the 
asymmetric unit. While there were no significant changes 
in the local environment of each activating mutation, 
alignment of four copies of each state revealed modest 
changes in the orientation of the COMM domain in the 
ligand-free structures. We used the extended-open state of 
PfTrpB (Figure 4a) as a reference point from which to 
measure the ‘openness’ of each protomer. Alignment to this 
common reference state shows that all structures match 
very well, with RMSD < 0.35 Å2 when using outlier rejec-
tion and we measured the displacement of Cα of each resi-
due from the reference state. Most regions show little varia-
tion (Figure S11). In some areas, such as the termini of the 
protein and the COMM domain, there were clear differ-
ences in the position of the residues among aligned subu-
nits of the same crystal structure (Figure 6a). We calculated 
the standard deviation of the distance of each residue from 
the reference state (Figure 6b), which constitutes and ex-
perimental measurement of crystallographic conformation-
al heterogeneity. Addition of Ser results in E(Aex1) for-
mation, partial closure of the COMM and a decrease in the 
conformational heterogeneity (Figure 6b). We repeated this 
analysis for each structure and found that, surprisingly, 
PfTrpB2B9 in its ligand-free state has a significant increase 
in the conformational heterogeneity compared to wild-type 
PfTrpB (Figure 7). This heterogeneity does not appear to be 
oriented randomly but is along the trajectory of closure 
(Figure 7a). Comparison to the E(Aex1) and E(A-A) inter-
mediates showed the heterogeneity diminishes once 
PfTrpB2B9 enters the catalytic cycle (Figure 7b). The signif-
icance of these changes is not immediately obvious. Previ-
ous studies have focused extensively on the role of changes 
in conformational dynamics during evolution.45–47 Often, 
B-factor analysis is used as a proxy for protein dynamics 
with the assumption that larger B-factors indicate higher 
conformational motion.47 We performed B-factor analysis 
for each structure and found a surprisingly poor correlation 
with the heterogeneity that is best illustrated with 
PfTrpB2B9 (Figure S12). B-factors were highest in a loop 
Figure 6.  Crystallographic conformational heterogeneity of PfTrpB. (a) Structure of PfTrpB in the extended-open conformation (PDB 
ID: 5T6M) is shown in light gray. The structure with no ligands bound is colored as a rainbow along the COMM domain and E(Ain) is 
shown in spheres. The COMM domain of PfTrpB-E(Aex1) is shown in dark gray. (b) Average distance and standard deviation to the 
extended-open conformation for each residue of PfTrpB in a unique state. PfTrpB with no ligands in the E(Ain) state (PDB ID: 5DVZ) is 
colored as a rainbow along the COMM domain. Comparison to the Ser-bound PfTrpB (PDB ID: 5DW0) in gray shows the heterogeneity 
is highest at sites that undergo motion upon closure of the COMM domain, whereafter the heterogeneity decreases. 
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 that forms several contacts with the α-subunit of the native 
complex but is highly mobile and not resolved in all struc-
tures of TrpB (Figure 8). In contrast, heterogeneity is larg-
est at in COMM domain, suggesting caution in interpreta-
tion of B-factors as a proxy for dynamics. 
 
 
DISCUSSION 
 The relationship between the protein conformational en-
semble and allostery is one of profound importance in bio-
chemistry and to the engineering of allosteric enzymes.22,48–
50 However, this relationship can be difficult to study and, 
as a result, previous investigations have focused on en-
zymes that catalyze comparatively simple reactions, typi-
cally hydrolysis and phosphoryl or hydride transfer. En-
zymes that catalyze multi-step transformations, such as 
TrpB, require the formation of multiple unique conforma-
tional states for catalysis. This implicit need for heteroge-
neity during the catalytic cycle further complicates analysis 
of the links between evolution, allostery and the 
ensemble.45,51–53 The present study addresses each of these 
factors by combining kinetic, thermodynamic, and structur-
al data for a lineage of TrpB enzymes that mimic allosteric 
activation. 
 Evolutionary tuning of the conformational equilibrium 
of the COMM domain drives allosteric mimicry. Many 
studies on allostery have focused on the importance of dis-
crete networks of residues that are involved in signal prop-
agation upon effector binding.48,54,55 Such networks have 
also been identified in the StTrpS complex, where remote 
mutations can shift the ensemble to favor open conforma-
tional states by disrupting hydrogen bonds56 or salt 
bridges57 that form upon COMM domain closure, thereby 
impeding catalysis. Mutations at the subunit interface can 
be similarly disruptive.58 Based on these studies, we initial-
ly hypothesized that activating mutations found agnostical-
ly through directed evolution would function along com-
plementary lines by forming discrete stabilizing interac-
tions, such as salt bridges and hydrogen bonds unique to 
the closed state of TrpB. However, analysis of multiple 
conformational states of the stand-alone enzymes by X-ray 
crystallography decisively failed to find any such obvious 
stabilizing effects (Figure S4, S5, S7). Understanding the 
structural consequences of mutation required integration of 
multiple lines of evidence that connect catalytic effects 
with the underlying conformational ensemble. 
We observed three distinct trends in our lineage of 
evolved enzymes. First, the RLS of catalysis shifts away 
from deprotonation of Cα, as indicated by KIE measure-
ments (Table 1). Unambiguous assignment of the new RLS 
requires rigorous pre-steady state analysis to probe the rates 
of the five chemical steps succeeding E(A-A) formation 
and is outside the scope of this investigation. Secondly, 
UV-vis spectroscopy revealed that activated, stand-alone 
enzymes accumulate E(Q3) and E(Aex2) in steady state. 
Given the conservation of structural and mechanistic fea-
tures between PfTrpS and its mesophilic homologs, litera-
ture precedence suggests proton transfer en route to 
E(Aex2) and/or release of product are the new RLS.
28,59 
Finally, these kinetic changes are associated with a ~100-
fold increase in the affinity for Trp and accompanied by a 
significant increase in the population of covalently bound 
Trp adducts at equilibrium. Each of these relationships is 
summarized by the reaction coordinate diagram in Figure 9. 
The structures of ligand-bound PfTrpB2B9 conclusively 
show that formation of the E(A-A) and E(Aex2) intermedi-
ates is coupled to formation of a fully closed conformation-
al state (Figure 4a, 5f). The solution data demonstrate that 
 
Figure 7.  Crystallographic conformational heterogeneity of PfTrpB2B9. (a) Structure of PfTrpB in the extended-open conformation (PDB 
ID: 5T6M), PfTrpB2B9-E(Aex1), and PfTrpB2B9-E(A-A) (PDB ID: 6AM9) are shown in increasingly dark shades of gray. The structure of 
PfTrpB2B9 with no ligands bound is colored as a rainbow along the COMM domain to match panel (b) Average distance and standard devi-
ation from the extended-open conformation to each residue of PfTrpB2B9 in a unique state. PfTrpB2B9 with no ligands in the E(Ain) state 
(PDB ID: 6AM7) is colored as a rainbow along the COMM domain. Comparison to PfTrpB2B9-E(Aex1) (PDB ID: 5VM5) in light gray and 
PfTrpB2B9-E(A-A) in dark grey shows the COMM domain heterogeneity decreases upon closure.  
 
Figure 8. Comparison of experimental conformational heteroge-
neity with B-factors. (a)  The heterogeneity of PfTrpB2B9is visual-
ized with the error bars in Figure 7b mapped onto the structure 
and colored from low (blue, thin) to high (red, thick).  (b) The B-
factor of each residue in chain B of PfTrpB2B9 is colored using the 
same scheme as panel (a) and shows that the maximum of the 
heterogeneity does not coincide with the maximum B-factor. 
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population of these catalytic intermediates steadily increas-
es throughout evolution, both at equilibrium and in steady 
state (Figure 3). Combined, these data establish that di-
rected evolution caused a stepwise change in the conforma-
tional coordinate to favor more closed states upon ligand 
binding.  
 
 
Figure 9. Hypothetical reaction coordinate diagram for PfTrpB 
enzymes. Energy levels are drawn (not to scale) to represent the 
relationship between the intermediates characterized in this study. 
The states that are lower in energy are those that are associated 
with a closed COMM domain. 
Structural and mechanistic comparison of the stand-
alone and allosterically activated TrpBs. Whereas the 
E(Aex2) structure reported here is unique, the closed con-
formational state of PfTrpB2B9 E(A-A) matches that deter-
mined for StTrpS (Figure S9). Our studies have revealed 
diverse, detailed mechanistic features of TrpB/TrpS cataly-
sis that are shared by distant homologs. First, Trp is synthe-
sized from IGP and Ser without accumulation of an indole 
intermediate (Figure 1a).16 Deuteration of the Ser α-carbon 
produces a negligible KIE (~1.0 for PfTrpS), and the 
steady-state population consists of covalently bound Trp 
adducts (Table 1, Figure 2f). Hence, the structure-function 
relationship between COMM domain closure and TrpB 
catalysis was conserved during the divergent evolution that 
separated P. furiosus and S. typhimurium. Previously, we 
showed that activating mutations discovered in PfTrpB 
were transferrable to distantly related homologs, including 
TrpB from E. coli.14 We hypothesize that this transferability 
works because the mutations are altering the energetics of 
this conserved feature of the ensemble.  
While remote mutations activate PfTrpB by stabilizing 
the closed conformational state, we lack understanding of 
how mutation accomplishes this feat. In principle, muta-
tions either decrease the energy of the closed state or in-
crease the energy of the open state. We suspect a combina-
tion of both factors is at play and the observation that the 
ground state of PfTrpB2B9 has increased conformational 
heterogeneity would be consistent with raising its energy. 
In contrast, the native allosteric effector (PfTrpA) causes 
similar kinetic changes, but forms a complex with very 
little conformational heterogeneity.12 Another, finer, dis-
tinction between PfTrpB2B9 and PfTrpS is the increased 
abundance of Trp-adducts in steady state (Figure S2). Giv-
en that the chemical and conformational states of TrpB are 
tightly coupled, we hypothesize that this difference be-
tween the engineered and allosterically-activated TrpBs is 
due to a difference in the rate of COMM domain motion. 
Such rates are invisible to both crystallographic and ther-
modynamic measurements but are highly relevant, given 
the conformational cycling that occurs during TrpB cataly-
sis (Figure 4a). 
 Such conformational effects may also underlie a previ-
ously perplexing observation: addition of PfTrpA to the 
engineered ‘allostery-mimicking’ enzymes does not result 
in further activation. Instead, the native β-substitution reac-
tion slows down, a phenomenon we call ‘allosteric inver-
sion’.12 A simple open-closed model, where the closed state 
is responsible for high catalytic activity, would suggest the 
effects of allosteric and mutational activation would be 
additive. We hypothesized that the observed allosteric in-
version could occur if activation causes the same mechanis-
tic changes, that is, decreasing the transition state barrier 
for the initial RLS while raising a new one. This scenario is 
borne out by the present study and simply adding these 
transition state effects could result in a higher barrier for 
the new RLS than for the original RLS of PfTrpB, causing 
mutant complexes to become sluggish catalysts.  
Mutational activation increases conformational het-
erogeneity. The directed evolution from PfTrpB4D11 to 
PfTrpB2B9 selected for increased total turnovers using Thr 
as the amino acid substrate. The data reported here show 
these mutations caused minimal loss of catalytic efficiency 
for the native reaction with Ser (Table 1). This contrasts 
with the previous efforts to study the evolution of new 
function. Previously, a phosphotriesterase was engineered 
into an aryl esterase, and the dynamics of the ensemble 
were probed by B-factor analysis.47 The parent hydrolase is 
highly specific for the native reaction, and has relatively 
little ground state heterogeneity. It was proposed that con-
formational dynamics first increase as the enzyme becomes 
a ‘generalist’, capable of performing both reactions. Con-
formational heterogeneity then decreases in later genera-
tions that are specialized for the novel reaction.47 This is a 
parsimonious explanation for the evolution of simple reac-
tions. The present study highlights how a more sophisticat-
ed model will be required to account for multi-step reac-
tions. For example, the kcat of the engineered TrpB enzymes 
after the first and last evolutionary steps are indistinguisha-
ble, despite dramatic differences in catalytic efficiency and 
Trp affinity. Also, PfTrpB2B9 operates efficiently with a 
greater range of substrates.13,35 Some of these differences 
may also reflect changes in the rate of a lyase reaction that 
is suppressed during the native reaction discussed here, but 
observable when substrate analogs are employed.13,16,35  
In general, enzymes that catalyze multi-step reactions 
(i.e. TrpB) require population of multiple discrete confor-
mational states for each iteration of the catalytic cycle and 
freezing out a single state would be deleterious to catalysis. 
Indeed, the full range of motion displayed in Figure 4a 
must be accomplished for each turnover. Future work to 
understand how mutational perturbation of the ensemble 
influences substrate specificity will require accounting for 
the rate of exchange between conformational states and 
may benefit from emerging molecular dynamics tech-
niques.21,60 
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CONCLUDING REMARKS 
Lineages of evolved enzymes have emerged as a rich re-
source for studying the connection between sequence and 
function. Spectroscopic data collected during our initial 
effort to evolve TrpB enzymes into efficient, stand-alone 
catalysts suggested that mutational activation operated in a 
similar fashion to native allosteric activation. The present 
study demonstrates that activating mutations in PfTrpB 
alter the conformational ensemble to favor closed states, 
which in turn shifts the RLS of catalysis. These are the pre-
cise effects induced by the native allosteric effecter, despite 
no explicit selection for shared conformational properties. 
We hypothesize this seemingly serendipitous convergence 
is a manifestation of the fact that allosteric enzymes are 
poised to respond to perturbation.61 This special sensitivity 
of their conformational ensemble likely also contributes to 
the unusually high frequency of activating mutations (over 
1% of randomly mutated variants of PfTrpB) that were 
found during directed evolution. Moreover, conservation of 
the allosteric activation mechanism throughout divergent 
evolution explains why activating mutations are so readily 
transferable between distant homologs. Hence, we believe 
that it may be feasible or even facile to engineer stand-
alone versions of other allosteric enzymes by directed evo-
lution without prior knowledge of the native allosteric 
mechanism.  
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